Skip to content
akaturk Academic measurement
2025 SJR Q1 JCR Q2 · 4,7 3 matched articles SCIE

Journal detail

JCO Precision Oncology

Publisher
Lippincott Williams and Wilkins
Country
United States · Northern America
Type
journal
ISSN
  • 24734284
Scopus 2,082 SJR
Scopus Q1 SJR Q
WoS Q2 JCR Q
WoS 4,7 JIF
Scopus 65 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 2,082
  • Quartile Q1
  • H-Index 65
  • Cites/doc 3,47
  • Docs (3y) 590
  • Cites (3y) 2.252

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q2
  • JIF 4,7
  • 5Y JIF 5,2
  • JCI 1,08

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Cancer Research Q1
  • Oncology Q1

Areas

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

WoS categories

  • Oncology

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q1 Q2 2,082 4,7 5,2 1,08 Q1 65
2024 Q1 Q1 2,409 5,8 5,5 1,11 Q1 56
2023 Q1 Q1 2,249 5,3 5,1 1,05 Q1 56
2022 Q1 Q2 2,208 4,6 6,1 0,85 Q2 56
2021 Q1 Q2 2,116 5,5 6,6 0,82 Q2 56
2020 Q1 Q2 2,405 4,9 5,8 0,8 Q2 56
2019 Q1 — 2,585 — — — — 56
2017 — — — — — — — 56

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 ONCOLOGY SCIE Q2 Q1 97/333
2024 ONCOLOGY SCIE Q1 Q1 56/328
2023 ONCOLOGY SCIE Q1 Q1 62/322
2022 ONCOLOGY SCIE Q2 Q2 89/241
2021 ONCOLOGY SCIE Q2 Q2 81/245
2020 ONCOLOGY SCIE Q2 Q2 96/242